Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor
Ting Li(Shanghai Medical College of Fudan University), Jin‐Jian Lu(University of Macau), Hong Zhu(Zhejiang University), Defang Ouyang(University of Macau), Bin Wei(Federal Reserve Bank of Atlanta), Qinjie Weng(ZheJiang Institute For Food and Drug Control), Hu‐Lin Jiang(China Pharmaceutical University), Xiuping Chen(University of Macau), Xin Chen(Chinese Academy of Sciences), Zhangjian Huang(China Pharmaceutical University), Xiaoyang Dai(ZheJiang Institute For Food and Drug Control), Ru Yan(University of Macau)
Cited by 44
Related Papers
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
|Nature|2000|3.3k
Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics
|Nature Communications|2021|297
A Comprehensive Map of FDA-Approved Pharmaceutical Products
|Pharmaceutics|2018|282
The Antioxidant Activity of Polysaccharides Derived from Marine Organisms: An Overview
|Marine Drugs|2019|252
Induction of ferroptosis and mitochondrial dysfunction by oxidative stress in PC12 cells
|Scientific Reports|2018|191